Search results for "Biomanufacturing" in Articles / App Notes
Article
Single-use Bioreactors Have Reached the Big Time
Automation and process control, both of which are essential to enabling consistent and reliable biomanufacturing, have improved greatly for single-use bioreactors as well. “Historically, single-use te…
Article
Perfusion in the 21st Century
Quality, flexibility, and cost savings are driving use of perfusion technology in biosimilars manufacturing.
By Bruce Lehr, Delia Lyons
Cell-culture technology for biopharmaceutical manufact…
Article
Biopharma Advances Demand Specialized Expertise
Also, the increasing trend toward outsourcing of GMP biologics manufacturing ensures bioprocessing and testing is performed by expert manufacturers with proven track records in quality and biomanufact…
Article
Relationship Building at Top of Mind for Clients
Figure 1: Selected outsourcing issues: biomanufacturing by CMOs.
This consideration has been moving up the rankings over the years. Of the 19 factors assessed, it was the fourth-most important back…
Article
Biosimilars Development and Supply: How Complex Can the Process Be?
As the complex requirements of manufacturing biologics are manifold, it is important that biomanufacturing companies adopt quality-by-design principles, which integrate quality control into the manufa…
Article
Flexibility in Biopharmaceutical Manufacturing
By: Simon Chalk
BioPharm International
There is a high degree of consensus in the biomanufacturing industry that product quality, customer service, and cost efficiency are fundamentals for suc…
Article
Overview of a scale-up of a cell-based influenza virus production process using ReadyToProcess equipment
Improved manufacturing agility and productivity
Biomanufacturing based on single-use technology offers great flexibility compared with traditional stainless steel facilities. Production lines can …
Article
Sterilization Trends for Single-Use Consumables
Single-use (SU) technologies increasingly find use today at all phases of the drug development cycle from preclinical to commercial manufacturing. As the biopharmaceutical market continues to …
Article
Explore ÄKTA pilot 600 in 3D
Cost and speed are critical components in biomanufacturing. See how ÄKTA pilot™ 600 supports scale-up from process development to GMP clinical scale.
Explore this ÄKTA™ system in…
Article
High-concentration monoclonal antibody drugs: manufacturing challenges
The growth in the formulation of drugs suitable for delivery by subcutaneous (Sub-C) injection highlights manufacturing challenges associated with the higher concentration of active ingredient…